Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of [18F]FPyQCP for PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07432633 is registered in ClinicalTrials.gov with Blue Earth Diagnostics as lead sponsor.

NCT NCT07432633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07432633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of [18F]FPyQCP for PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Lead sponsor
Blue Earth Diagnostics
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 19, 2026
Completion date
January 31, 2028
Enrollment
71 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, epithelial ovarian cancer, gastric cancer, invasive lobular breast carcinoma, pancreatic ductal adenocarcinoma